Skip to main content
SpringerLink
Log in

Mirtazapine-related risk of hypothyroxinaemia

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. thyroid feedback quantile-based index

Reference

  • Zhao Y, et al. Mirtazapine use may increase the risk of hypothyroxinemia in patients affected by major depressive disorder. British Journal of Clinical Pharmacology : 12 Jun 2021. Available from: URL: http://doi.org/10.1111/bcp.14949

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mirtazapine-related risk of hypothyroxinaemia. Reactions Weekly 1862, 9 (2021). https://doi.org/10.1007/s40278-021-98127-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-98127-x

Search

Navigation